Feedback
  • Article / Essay
  • Editorial: Advances in non-alcoholic fatty liver disease therapeutics:…

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets

Affiliation
Department of Physiology ,Faculty of Medicine ,University of Valencia ,Valencia ,Spain
Blas-García, Ana;
Affiliation
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) ,Madrid ,Spain
Cubero, Francisco Javier

Preview

Category

Published in:
Frontiers in Pharmacology
Vol. 13 (10.11.2022)
Volume:
13
Date Issued:
10.11.2022
DOI:
10.3389/fphar.2022.1072353
Language:
English
Type of Resource:
Text
Keywords:
NAFLD; liver; therapy; gut; microbiome; NASH
DDC subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2022 Blas-García and Cubero.

Use and reproduction: